Last update 19 Sep 2024
Emergent BioSolutions, Inc.

Emergent BioSolutions, Inc.

Public Company|
1998|
Maryland, United States
|
1,000-5,000
| NYSE: EBS|

Overview

Basic Info

Introduction
Operating in the field of medical countermeasure development, manufacturing, and sales, Emergent BioSolutions Inc. provides products for both civilian and military entities, addressing public health threats, whether accidental, deliberate, or naturally occurring. The portfolio of the company encompasses ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Business sectors under Emergent's purview include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development & Manufacturing. Initiated by Fuad El-Hibri on September 5th, 1998, the company's headquarters is established in Gaithersburg, MD.

Tags

Infectious Diseases
Other Diseases
Respiratory Diseases
Small molecule drug
Prophylactic vaccine
Immunoglobulin

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug10
Prophylactic vaccine8
Immunoglobulin5
Vaccine4
Live attenuated vaccine3

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 11 Oct 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
12
3
Phase 1 Clinical
Phase 2 Clinical
2
2
Phase 3 Clinical
Approved
11
41
Other
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free